Breaks Categories: News

TuesdaySep 24, 2024 2:18 pm

NetworkNewsBreaks – The MoneyShow Orlando: Politics and Your Money Promises to Help Investors Navigate Uncertainty Surrounding the US Presidential Elections

MoneyShow, a leading producer of financial conferences for affluent investors, active traders and financial advisors, is announcing plans to host The MoneyShow Orlando: Politics and Your Money. The three-day event will be held on October 17-19, 2024, at the Omni Orlando Resort at ChampionsGate. The event is designed to help attendees evaluate the strength of their portfolio as the U.S. presidential election nears, build a sound understanding of the spectrum of probabilities across asset classes, and adjust holdings to ensure robustness, return, and agility heading into 2025 and beyond. The event will feature 40+ presentations across two stages, in-depth workshops,…

Continue Reading

TuesdaySep 24, 2024 1:21 pm

NetworkNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) Partners with Volkswagen to Integrate AI Assistant in Vehicles

Alphabet (NASDAQ: GOOGL, GOOG), through its subsidiary Google, has embarked on an innovative partnership with Volkswagen to integrate an artificial intelligence (“AI”) assistant into Volkswagen vehicles. This collaboration is a strategic move by Google to penetrate deeper into the automotive industry, leveraging its advanced AI and cloud computing technologies. The AI assistant is designed to enhance the driving experience by providing vehicle-related information and assistance through a user-friendly smartphone app. This initiative is part of Google’s broader ambition to expand its footprint in the enterprise AI application sector, showcasing its commitment to leveraging technology to solve real-world problems. The technical…

Continue Reading

TuesdaySep 24, 2024 12:40 pm

NetworkNewsBreaks – Ederra CEO Spotlighted in Most Recent Episode of Bell2Bell Podcast

Ederra, a farm-to-body wellness brand that combines nature and cutting-edge science to create innovative, functional supplements for brain and body longevity, is featured in the latest release of the Bell2Bell Podcast. According to the announcement, Ederra CEO Vladi Delsoglio is the featured guest in the most recent episode of the podcast, which provides informative updates and exclusive interviews with executives leading companies in fast-moving industries. The Bell2Bell Podcast is sponsored by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community. During the episode, Delsoglio and podcast host Carmel Fisher discussed the founding of Ederra, and…

Continue Reading

TuesdaySep 24, 2024 12:27 pm

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Names Industry Expert, Pioneer as New Chief AI Scientist

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, has appointed a new chief artificial intelligence (“AI”) scientist: Lance Myers, PhD. According to the announcement, Myers is the former head of data science at Verily, formerly Google Life Sciences. A renowned industry leader and pioneer in digital health data analytics and body-worn biosensor technologies, Myers is a globally respected authority on utilizing AI in biosensor tech. In his new position, Myers will drive innovation and strategic growth for HeartBeam as the company looks to fully leverage its AI…

Continue Reading

TuesdaySep 24, 2024 12:17 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Awarded DV Electronic Monitoring Contract by Government of European Country

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has secured a three-year national contract with the government of a European country. The contract calls for SuperCom deploy its PureSecurity domestic violence (“DV”) monitoring solution. Since entering the market, SuperCom has become a leader in Europe’s national domestic violence monitoring sector, deploying a substantial number of units and outpacing its competitors. This new contract further solidifies the company’s continued expansion in the region as it works to enhancing domestic violence prevention and intervention capabilities. “We are honored to collaborate with this…

Continue Reading

TuesdaySep 24, 2024 11:15 am

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Shares Video Update from CEO

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today shared a video update to shareholders provided by CEO and Chairman David Michery. In the video, Michery provides a detailed overview of the company’s recent progress, including sales and distribution expansion and financial performance. According to the update, the company’s sales activities with existing and new companies have resulted in new sales opportunities and vehicle orders received and or completed. Additionally, Mullen has secured financing to support sales growth through a $100 million preferred instrument and a $150 million fully available equity line. The update also highlighted Bollinger Motors’…

Continue Reading

TuesdaySep 24, 2024 10:00 am

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology

Nutriband (NASDAQ: NTRB), a pharmaceutical company with a special focus on transdermal technologies, is announcing that its patent application, which protects its AVERSA(TM) abuse deterrent transdermal technology, has been allowed in China. This follows the receipt of a Notice of Allowance from the Chinese National Intellectual Property Administration (“CNIPA”) for the application entitled “Abuse and Misuse Deterrent Transdermal Systems.” The latest allowance expands the company’s international intellectual property portfolio, which now includes patents issued in 46 countries: Australia, Canada, China, Europe, Japan, Korea, Mexico, Russia, the U.S., and more. To view the full press release, visit https://nnw.fm/GJOFB About Nutriband Inc.…

Continue Reading

MondaySep 23, 2024 1:32 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN), Subsidiary Celebrate Production of B4 Electric Truck, CEO to Release Shareholder Update Video

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, and its subsidiary, Bollinger Motors, are announcing a major milestone. According to the announcement, the first customer-ready B4 electric truck rolled off the production line in Livonia, Michigan, last week. Employees, suppliers and government officials gathered on Sept. 20, 2024, to celebrate the production of the first customer-ready, all-electric Class 4 Bollinger B4 Chassis Cab. The vehicle, which is produced in partnership with Roush Industries, is entirely assembled in the United States. “Robert Bollinger and his team made a gutsy call two years ago to pivot to an entirely different market…

Continue Reading

MondaySep 23, 2024 11:20 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe Forum

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that CEO John Climaco will present at the 24th Annual Biotech in Europe Forum. The presentation is scheduled for Wednesday, September 25, 2024, at 1:55 p.m. CEST in Basel, Switzerland. Additionally, management will participate in in-person one-on-one meetings with qualified members of the investor community who are registered to attend the conference. To view the full press release, visit https://nnw.fm/tantX About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing…

Continue Reading

MondaySep 23, 2024 10:45 am

NetworkNewsBreaks – TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Completes ACHIEVE Trial Full-Dose Regimen for First Patient

TC Biopharm (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, has announced a key step in its ACHIEVE clinical trial. According to the announcement, the first patient has completed the full-dose regimen in the phase 2b trial. In addition, the company announced that six patients have received a second dose and three patients have received a third dose; patients can receive up to four total doses of TCB under the trial protocol. Furthermore, no TCB008-related adverse events have been observed in any of the restart patients. To view the full press release, visit…

Continue Reading